药物对比
Acarbose vs Pioglitazone
比较Acarbose（Precose）与Pioglitazone（Actos）治疗2型糖尿病：餐后胃肠道作用vs噻唑烷二酮类胰岛素增敏剂，后者有心力衰竭和体重增加风险。
此页面暂无可用的对比维度。
临床背景
Type 2 diabetes patients weighing an inexpensive oral postprandial agent against a thiazolidinedione insulin sensitizer that improves insulin resistance but risks heart failure and weight gain.
结论
Pioglitazone generally delivers greater efficacy and insulin sensitization while Acarbose remains a simple oral choice with mainly GI effects, so selection is highly individualized.
全部药物对比